Evidence map›Paper›PMID 33110622›Full record

ArticlePilot and feasibility studies2020

Prevention of post-cardiac surgery vitamin D deficiency in children with congenital heart disease: a pilot feasibility dose evaluation randomized controlled trial.

James Dayre McNally, Katie O'Hearn, Dean A Fergusson, Jane Lougheed, Dermot R Doherty, Gyaandeo Maharajh, Hope Weiler, Glenville Jones, Ali Khamessan, Stephanie Redpath and 6 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Pilot and feasibility studies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01838447 (Prevention of Post-Cardiac Surgery Vitamin D Deficiency in Children With Congenital Heart Disease), which is not on this map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01838447 phase2completednot on this map

Prevention of Post-Cardiac Surgery Vitamin D Deficiency in Children With Congenital Heart Disease: A Pilot Dose Evaluation Randomized Controlled Trial

TypeinterventionalSponsorChildren's Hospital of Eastern OntarioRan2013 to 2015Enrolled46ConditionsVitamin D Deficiency, Thoracic Surgery, Pediatric Disorders, Heart Defects, CongenitalArmsCholecalciferol
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

James Dayre McNallyDepartment of Pediatrics, Division of Critical Care, University of Ottawa, Ottawa, Canada.ORCID 0000-0001-8103-9967
Katie O'HearnChildren's Hospital of Eastern Ontario Research Institute, Ottawa, Canada.
Dean A FergussonDepartment of Medicine, University of Ottawa, Ottawa, Canada.
Jane LougheedDepartment of Pediatrics, Division of Cardiology, University of Ottawa, Ottawa, Canada.
Dermot R DohertyChildren's Health Ireland at Temple Street, Dublin, Ireland.
Gyaandeo MaharajhDepartment of Pediatric Surgery, Division of Cardiovascular Surgery, University of Ottawa, Ottawa, Canada.
Hope WeilerSchool of Human Nutrition, Faculty of Agricultural and Environmental Sciences, McGill University, Montreal, Canada.
Glenville JonesSchool of Medicine, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada.
Ali KhamessanEuro-Pharm International Canada Inc., Montreal, Canada.
Stephanie RedpathDepartment of Pediatrics, Division of Neonatology, University of Ottawa, Ottawa, Canada.
Pavel GeierDepartment of Pediatrics, Division of Nephrology, University of Ottawa, Ottawa, Canada.
Lauralyn McIntyreDepartment of Medicine (Division of Critical Care), Ottawa Hospital Research Institute (OHRI), University of Ottawa, Ottawa, Canada.
Margaret L LawsonDepartment of Pediatrics, Division of Endocrinology, University of Ottawa, Ottawa, Canada.
Tara GirolamoDepartment of Pediatric Surgery, Division of Cardiovascular Surgery, University of Ottawa, Ottawa, Canada.
Kusum MenonDepartment of Pediatrics, Division of Critical Care, University of Ottawa, Ottawa, Canada.
Canadian Critical Care Trials Group
University of Ottawa · CAChildren's Hospital of Eastern Ontario · CAMcGill University · CAQueen's University · CATemple Street Children's University Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe vast majority of children undergoing cardiac surgery have low vitamin D levels post-operative, which may contribute to greater illness severity and worse clinical outcomes. Prior to the initiation of a large phase III clinical trial focused on clinical outcomes, studies are required to evaluate the feasibility of the study protocol, including whether the proposed dosing regimen can safely prevent post-operative vitamin D deficiency in this high-risk population.

methodsWe conducted a two-arm, double-blind dose evaluation randomized controlled trial in children requiring cardiopulmonary bypass for congenital heart disease. Pre-operatively, participants were randomized to receive cholecalciferol representing usual care (< 1 year = 400 IU/day, > 1 year = 600 IU/day) or a higher dose approximating the Institute of Medicine tolerable upper intake level (< 1 year = 1600 IU/day, > 1 year = 2400 IU/day). The feasibility outcomes were post-operative vitamin D status (primary), vitamin D-related adverse events, accrual rate, study withdrawal rate, blinding, and protocol non-adherence.

resultsForty-six children were randomized, and five withdrew prior to surgery, leaving 41 children (21 high dose, 20 usual care) in the final analysis. The high dose group had higher 25-hydroxyvitamin D concentrations both intraoperatively (mean difference + 25.9 nmol/L; 95% CI 8.3-43.5) and post-operatively (mean difference + 17.2 nmol/L; 95% CI 5.5-29.0). Fewer participants receiving high-dose supplementation had post-operative serum 25-hydroxyvitamin D concentrations under 50 nmol/L, compared with usual care (RR 0.31, 95% CI 0.11-0.87). Post-operative vitamin D status was associated with the treatment arm and the number of doses received. There were no cases of hypercalcemia, and no significant adverse events related to vitamin D. While only 75% of the target sample size was recruited (limited funding), the consent rate (83%), accrual rate (1.5 per site month), number of withdrawals (11%), and ability to maintain blinding support feasibility of a larger trial.

conclusionsPre-operative daily high-dose supplementation improved vitamin D status pre-operatively and at time of pediatric ICU admission. The protocol for a more definitive trial should limit enrollment of children with at least 30 days between randomization and surgery to allow adequate duration of supplementation or consider a loading dose.

trial registrationClinicalTrials.gov, NCT01838447. Registered on April 24, 2013.

Indexed as

CholecalciferolCongenital heart diseaseCritical careDose evaluation trialHigh-dosePediatric intensive care unitVitamin D deficiency

Identifiers

PMID33110622
PMCPMC7583219
OpenAlexW3094337181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.